CCR7 and metastatic malignant neoplasm in the lymph nodes: For example, CCR7 has been demonstrated as a biomarker that can predict lymph node metastases in breast cancer, and as a metastasis and prognosis indicator in patients with esophageal carcinoma (Liu et al., 2013).